Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc-regulated GTPase metalloprotein activator 1C (ZNG1C) is a protein-coding gene product that functions as a zinc chaperone, specifically facilitating the direct transfer of zinc as a cofactor to target metalloproteins, thereby activating them[1][4]. ZNG1C performs this role by catalyzing zinc insertion into the active site of methionine aminopeptidase METAP1, a critical enzyme that removes the initiator methionine from polypeptides during or after translation. Mechanistically, ZNG1C uses motifs in its N-terminal and GTPase domain to dock with inactive METAP1, undergoes GTP hydrolysis-dependent zinc transfer, and releases the now-active METAP1 after GTP/GDP exchange. While ZNG1C is predicted to be present in the cytoplasm and nucleus, detailed information on tissue-specific roles, disease correlations, or therapeutic targeting is currently lacking[1][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc-regulated GTPase metalloprotein activator 1C (ZNG1C).